Evidence map›Paper›PMID 29103592›Full record

ArticleVaccine2017

Moving forward on strengthening and sustaining National Immunization Technical Advisory Groups (NITAGs) globally: Recommendations from the 2nd global NITAG network meeting.

Noni E MacDonald, Philippe Duclos, Ole Wichmann, Louise Henaff, Anthony Harnden, Aisha Alshammary, Roberto Arroba Tijerino, Madeline Hall, Jahit Sacarlal, Rupa Rajbhandari Singh

Abstract read
In one paragraph

Article in Vaccine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Noni E MacDonaldDepartment of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: noni.macdonald@dal.ca.
Philippe DuclosDepartment of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Ole WichmannImmunization Unit, Robert Koch Institute, Berlin, Germany.
Louise HenaffDepartment of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Anthony HarndenNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
Aisha AlshammaryDepartment of Pediatrics, Alyamamah Hospital, Riyadh, Saudi Arabia.
Roberto Arroba TijerinoNational Commission on Vaccination and Epidemiology, Ministry of Health, San Jose, Costa Rica.
Madeline HallVaccine Preventable Diseases, Royal Brisbane and Women's Hospital, Queensland Health, Brisbane, Australia.
Jahit SacarlalFaculdade de Medicina, Universidade Eduardo Mondlane, Maputo, Mozambique.
Rupa Rajbhandari SinghDept. of Pediatrics, BP Koirala Institute of Health Sciences, Dharan, Nepal.

Funding

World Health Organization 001
6 · The paper itself

Abstract

National Immunization Technical Advisory Groups (NITAGs) provide independent, evidence-informed advice to assist their governments in immunization policy formation. This is complex work and many NITAGs face challenges in fulfilling their roles. Inter-country NITAG collaboration opportunities have the potential to enhance NITAG function and grow the quality of recommendations. Hence the many requests for formation of a network linking NITAGs together so they can learn from each other. The first Global NITAG Network (GNN) meeting, held in 2016, led to a push to launch the GNN and grow the network. At the second GNN meeting, held June 28-29, 2017 in Berlin, the GNN was formally inaugurated. Participants discussed GNN governance, reflected on the April 2017 Strategic Advisory Group of Experts (SAGE) on Immunization conclusions concerning strengthening of NITAGs and also shared NITAG experiences in evaluation and inter-country collaborations and independence. They also discussed the role of Regional Technical Advisory Groups on Immunization (RTAGs) and regional networks. A number of issues were raised including NITAGs and communications, dissemination of recommendations and vaccine implementation as well as implications of off-label recommendations. Participants were alerted to immunization evidence assessment sites and value of sharing of resources. They also discussed potential GNN funding opportunities, developed an action plan for 2017-18 and selected a Steering Committee to help move the GNN forward. All participants agreed on the importance of the GNN and the value in attracting more countries to join the GNN.

Indexed as

Advisory CommitteesHealth PolicyHumansImmunization ProgramsInternational CooperationAdvisory committeeEvaluationEvidence-based immunization policyGlobal networkGlobal NITAG networkImmunizationNational Immunization Technical Advisory GroupNITAGVaccine decision-making

Identifiers

PMID29103592
PMCPMC6278871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.